HOME - Clinical cases - Oral pathology
 
 
08 August 2023

NYU’s Rodrigo Lacruz lands funding to study biology of oral health in people with Down syndrome

By NYU News


Rodrigo Lacruz, professor of molecular pathobiology at NYU Dentistry, has received a grant from the National Institute of Dental and Craniofacial Research (NIDCR) and the National Institutes of Health’s INCLUDE project to study salivary gland and tooth enamel formation on a molecular level in those with Down syndrome. 

According to a NYU news story, the five-year grant provides $1.5 million in funding for the initial three-year period, with additional funding in the ensuing two years.

This research will build on Lacruz’s existing work on the oral health of people with genetic disorders including Down syndrome, also supported by funding from NIDCR. Lacruz received a five-year, $2.3 million grant earlier this year to support his work on the role of mitochondria in the formation of tooth enamel in those with genetic disorders.

People with Down syndrome face several issues with their oral health, including poor saliva production and defects in their tooth enamel, which can present as thinner enamel and hypomineralization. The molecular mechanisms responsible for these differences are not known.

Saliva is essential to overall oral health, preventing bacterial growth that can lead to cavities and helping with speech and taste. Saliva and tooth enamel together provide a barrier against bacteria, and deficiencies in them can have a significant impact on health and quality of life.

The goal of this research is to understand how salivary gland and enamel formation are altered in Down syndrome on a molecular level and to define the role of a gene called RCAN1 and a protein called calcineurin in this process. The researchers will use mouse models of Down syndrome to study whether RCAN1 disrupts enamel crystal formation in Down syndrome by altering mitochondrial function in ameloblasts, and whether suppressing calcineurin signaling disrupts calcium signaling in salivary glands, leading to poor saliva production.

In a news release, Lacruz said this research will advance understanding of the mechanisms through which changes in normal mitochondrial function, such those associated with Down syndrome, impact oral health and will elucidate the mechanisms contributing to poor saliva production in this population.

Grants cited in this article include 1R01DE032846-01 and 2R01DE027679-05.

Learn more at: https://dental.nyu.edu/

Related articles

Matregenix announced a grant award from the National Institute of Dental & Craniofacial Research under the auspices of the Small Business Innovation Research (SBIR) program and National Institutes of Health (NIH). The grant will be utilized to develop a n

Guided bone regeneration (GBR) is a common technique used in the dental industry for the treatment of bony defects, among other conditions. Barrier membranes are crucial components of GBR procedures,...


Community health system, Montefiore Medicine, and Congressmen Adriano Espaillat and Ritchie Torres garnered $3.3 million in federal funding for the Montefiore School Health Program (MSHP), which...


The Down syndrome (DS) is a congenital anomaly, affecting individuals of either gender and it is associated with an extra copy of the chromosome 21. The objective of this case report was to describe...


vVARDIS's products will be available online at bluemercury.com and in stores at 50 retail locations across the U.S.


Dr. Louis Mandel, who has served as a professor of oral and maxillofacial surgery at Columbia University College of Dental Medicine since 1951, has published Clinical Management of Salivary Gland...


Read more

For a variety of reasons, orthodontic intervention is often overlooked as a viable modality to correct occlusal, axial, rotational, and space discrepancies before undertaking fixed prosthetic...


Congratulations to Ane Poly, D.D.S., M.Sc., Ph.D., a clinical assistant professor in the UF Department of Endodontics, who was recently chosen as the college’s representative to the Council of...


ONEDAYBIOTECH products garner honor as one of the 16th Annual Readers’ Choice Top 25 Implant Products


National leader in oral health integration and equity joins CareQuest Institute executive team.


Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of...


 
 
 
 

 
 
 
 

Most popular

 
 

Events